ASCEND Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- ASCEND Therapeutics's estimated annual revenue is currently $42.4M per year.
- ASCEND Therapeutics's estimated revenue per employee is $201,000
Employee Data
- ASCEND Therapeutics has 211 Employees.
ASCEND Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Commercial Operations | Reveal Email/Phone |
3 | Executive Director, Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
4 | Associate Director, Trade and Market Access | Reveal Email/Phone |
5 | Sr. Director, Marketing | Reveal Email/Phone |
6 | Senior Director Human Resources | Reveal Email/Phone |
7 | Associate Manager, Training and Development | Reveal Email/Phone |
8 | District Manager | Reveal Email/Phone |
9 | Senior Manager, Medical Affairs | Reveal Email/Phone |
10 | Sr. Manager, Compliance & Quality | Reveal Email/Phone |
ASCEND Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.5M | 21 | -12% | $1.8M | N/A |
What Is ASCEND Therapeutics?
ASCEND Therapeutics is a biopharmaceutical company focused on the research, development and use of transdermal drug delivery technology to overcome therapeutic barriers and raise the standard of care for previously unmet chronic health conditions. Founded in 2002 and based in Herndon, VA, ASCEND uses its proprietary percutaneous hydroalcoholic gel technology to deliver therapy in instances where oral delivery is impossible or undesirable
keywords:N/AN/A
Total Funding
211
Number of Employees
$42.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
ASCEND Therapeutics News
... Tolmar Pharmaceuticals, Inc., Novartis AG, Upsher-Smith Laboratories Inc., SottoPelle, Neuva Aesthetics, Ascend Therapeutics.
Basil Darras, MD, offered his perspective on the ASCEND study ... to another approved therapy, risdiplam (Evrysdi; PTC Therapeutics).
NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, ... the potential for the ASCEND clinical trial, combined with the GEMINI...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35.6M | 223 | 5% | N/A |
#2 | $35M | 227 | -8% | N/A |
#3 | $37.1M | 238 | 8% | $77.1M |
#4 | $85.8M | 240 | -10% | N/A |
#5 | $39.2M | 246 | 0% | N/A |